164 related articles for article (PubMed ID: 24258815)
21. P2X1 Receptors Amplify FcγRIIa-Induced Ca2+ Increases and Functional Responses in Human Platelets.
Ilkan Z; Watson S; Watson SP; Mahaut-Smith MP
Thromb Haemost; 2018 Feb; 118(2):369-380. PubMed ID: 29443373
[TBL] [Abstract][Full Text] [Related]
22. Glycoprotein Ib-mediated platelet activation. A signalling pathway triggered by thrombin.
Adam F; Guillin MC; Jandrot-Perrus M
Eur J Biochem; 2003 Jul; 270(14):2959-70. PubMed ID: 12846829
[TBL] [Abstract][Full Text] [Related]
23. A novel mechanism of sustained platelet αIIbβ3 activation via PEAR1.
Kauskot A; Di Michele M; Loyen S; Freson K; Verhamme P; Hoylaerts MF
Blood; 2012 Apr; 119(17):4056-65. PubMed ID: 22371881
[TBL] [Abstract][Full Text] [Related]
24. Cancer cell-derived immunoglobulin G activates platelets by binding to platelet FcγRIIa.
Miao S; Shu D; Zhu Y; Lu M; Zhang Q; Pei Y; He AD; Ma R; Zhang B; Ming ZY
Cell Death Dis; 2019 Jan; 10(2):87. PubMed ID: 30692520
[TBL] [Abstract][Full Text] [Related]
25. The toll-like receptor 2/1 (TLR2/1) complex initiates human platelet activation via the src/Syk/LAT/PLCγ2 signalling cascade.
Fälker K; Klarström-Engström K; Bengtsson T; Lindahl TL; Grenegård M
Cell Signal; 2014 Feb; 26(2):279-86. PubMed ID: 24240055
[TBL] [Abstract][Full Text] [Related]
26. Molecular mechanisms of platelet activation and aggregation induced by breast cancer cells.
Zarà M; Canobbio I; Visconte C; Canino J; Torti M; Guidetti GF
Cell Signal; 2018 Aug; 48():45-53. PubMed ID: 29705335
[TBL] [Abstract][Full Text] [Related]
27. Analysis of FcgammaRIIA cytoplasmic tail requirements in signaling for serotonin secretion: evidence for an ITAM-dependent, PI3K-dependent pathway.
Daniels AB; Worth RG; Dickstein RJ; Dickstein JS; Kim-Han TH; Kim MK; Schreiber AD
Scand J Immunol; 2010 Apr; 71(4):232-9. PubMed ID: 20384866
[TBL] [Abstract][Full Text] [Related]
28. Impact of the PI3-kinase/Akt pathway on ITAM and hemITAM receptors: haemostasis, platelet activation and antithrombotic therapy.
Moroi AJ; Watson SP
Biochem Pharmacol; 2015 Apr; 94(3):186-94. PubMed ID: 25698506
[TBL] [Abstract][Full Text] [Related]
29. Platelet alpha IIb-beta 3 integrin engagement induces the tyrosine phosphorylation of Cbl and its association with phosphoinositide 3-kinase and Syk.
Saci A; Rendu F; Bachelot-Loza C
Biochem J; 2000 Nov; 351 Pt 3(Pt 3):669-76. PubMed ID: 11042121
[TBL] [Abstract][Full Text] [Related]
30. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
Wang WY; Wu YC; Wu CC
Mol Pharmacol; 2006 Oct; 70(4):1380-9. PubMed ID: 16837624
[TBL] [Abstract][Full Text] [Related]
31. cAMP- and cGMP-elevating agents inhibit GPIbα-mediated aggregation but not GPIbα-stimulated Syk activation in human platelets.
Makhoul S; Trabold K; Gambaryan S; Tenzer S; Pillitteri D; Walter U; Jurk K
Cell Commun Signal; 2019 Sep; 17(1):122. PubMed ID: 31519182
[TBL] [Abstract][Full Text] [Related]
32. Platelet glycoprotein VI promotes metastasis through interaction with cancer cell-derived galectin-3.
Mammadova-Bach E; Gil-Pulido J; Sarukhanyan E; Burkard P; Shityakov S; Schonhart C; Stegner D; Remer K; Nurden P; Nurden AT; Dandekar T; Nehez L; Dank M; Braun A; Mezzano D; Abrams SI; Nieswandt B
Blood; 2020 Apr; 135(14):1146-1160. PubMed ID: 32040544
[TBL] [Abstract][Full Text] [Related]
33. Platelet 12-LOX is essential for FcγRIIa-mediated platelet activation.
Yeung J; Tourdot BE; Fernandez-Perez P; Vesci J; Ren J; Smyrniotis CJ; Luci DK; Jadhav A; Simeonov A; Maloney DJ; Holman TR; McKenzie SE; Holinstat M
Blood; 2014 Oct; 124(14):2271-9. PubMed ID: 25100742
[TBL] [Abstract][Full Text] [Related]
34. Selective association of the tyrosine kinases Src, Fyn, and Lyn with integrin-rich actin cytoskeletons of activated, nonaggregated platelets.
Bertagnolli ME; Hudson LA; Stetsenko GY
Biochem Biophys Res Commun; 1999 Jul; 260(3):790-8. PubMed ID: 10403844
[TBL] [Abstract][Full Text] [Related]
35. Toll like receptor 2/1 mediated platelet adhesion and activation on bacterial mimetic surfaces is dependent on src/Syk-signaling and purinergic receptor P2X1 and P2Y12 activation.
Klarström Engström K; Brommesson C; Kälvegren H; Bengtsson T
Biointerphases; 2014 Dec; 9(4):041003. PubMed ID: 25553878
[TBL] [Abstract][Full Text] [Related]
36. Involvement of proline-rich tyrosine kinase 2 in platelet activation: tyrosine phosphorylation mostly dependent on alphaIIbbeta3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2.
Ohmori T; Yatomi Y; Asazuma N; Satoh K; Ozaki Y
Biochem J; 2000 Apr; 347(Pt 2):561-9. PubMed ID: 10749687
[TBL] [Abstract][Full Text] [Related]
37. CLEC-2 expression is maintained on activated platelets and on platelet microparticles.
Gitz E; Pollitt AY; Gitz-Francois JJ; Alshehri O; Mori J; Montague S; Nash GB; Douglas MR; Gardiner EE; Andrews RK; Buckley CD; Harrison P; Watson SP
Blood; 2014 Oct; 124(14):2262-70. PubMed ID: 25150298
[TBL] [Abstract][Full Text] [Related]
38. Amplification of bacteria-induced platelet activation is triggered by FcγRIIA, integrin αIIbβ3, and platelet factor 4.
Arman M; Krauel K; Tilley DO; Weber C; Cox D; Greinacher A; Kerrigan SW; Watson SP
Blood; 2014 May; 123(20):3166-74. PubMed ID: 24642751
[TBL] [Abstract][Full Text] [Related]
39. Loss of Reelin protects mice against arterial thrombosis by impairing integrin activation and thrombus formation under high shear conditions.
Gowert NS; Krüger I; Klier M; Donner L; Kipkeew F; Gliem M; Bradshaw NJ; Lutz D; Köber S; Langer H; Jander S; Jurk K; Frotscher M; Korth C; Bock HH; Elvers M
Cell Signal; 2017 Dec; 40():210-221. PubMed ID: 28943410
[TBL] [Abstract][Full Text] [Related]
40. Syk Activity Is Dispensable for Platelet GP1b-IX-V Signaling.
Badolia R; Kostyak JC; Dangelmaier C; Kunapuli SP
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28598382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
